News Does the Novavax delay augur a COVID vaccine policy change? Statements from HHS suggest new hurdles could be coming for seasonal COVID formulations, though the picture is still unclear.
Patients Protecting the immunocompromised: Preventative measures agai... COVID-19 vaccines are not as effective in immunocompromised individuals as they are in the general population, due to an inability to produce a robust protective response to the vaccine.
Views & Analysis Not just COVID-19 vaccines: 5 things that cause blood clots Reports of COVID-19 vaccinations causing blood clots has caused alarm in the general population.
Oncology ASCO 2026: Chinese firms take a front seat in oncology, with... Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
